Identifying and Treating Steroid-Induced Psychosis in MS Patients Using Quetiapine
Background: High-dose corticosteroids (CS) (1g IV methylprednisolone or 1250 mg oral prednisone for 3-5 days) is the most common treatment...
How the COVID-19 Pandemic Has Changed Multiple Sclerosis Clinical Practice: Results of a Nationwide Provider Survey
Background: The COVID-19 crisis has created unanticipated changes in health care delivery for people living with multiple sclerosis (MS)....
The Effect of Telerehabilitation on the Quality of Life and Fatigue of Patients with Multiple Sclerosis
Background: , Multiple Sclerosis is a chronic neurological disease, characterized by demyelination of neurons in the Central Nervous System...
Characterizing Socioeconomic, Lifestyle, and Comorbidity Mediators of Racial Disparities in Ambulatory Impairments in Multiple Sclerosis.
Background: Multiple sclerosis (MS) is more prevalent in White Americans (WAs), yet incidence is now highest in Black Americans (BAs), who...
Improving the Utilization of Standardized Mris in Multiple Sclerosis Care: A Pragmatic Trial Perspective
Background: Magnetic resonance imaging (MRI) is a key part of the diagnosis and follow-up of people with multiple sclerosis (MS). However,...